Engineered Nanoplatelets for Enhanced Treatment of Multiple Myeloma and Thrombus

Targeted drug delivery to circulating tumor cells via platelet membrane-functionalized particles

(2016) Jiahe Li et al.   BIOMATERIALS

Tumor Microenvironment-Mediated Construction and Deconstruction of Extracellular Drug-Delivery Depots

(2016) Quanyin Hu et al.   NANO LETTERS

A Facile Approach to Functionalize Cell Membrane-Coated Nanoparticles

(2016) Hao Zhou et al.   Theranostics

Anticancer Platelet-Mimicking Nanovehicles

(2015) Quanyin Hu et al.   ADVANCED MATERIALS

Nanoparticle biointerfacing by platelet membrane cloaking

(2015) Che-Ming J. Hu et al.   NATURE

Clot-Targeted Micellar Formulation Improves Anticoagulation Efficacy of Bivalirudin

(2014) Zhi-Gang She et al.   ACS Nano

Curing myeloma at last: defining criteria and providing the evidence

(2014) B. Barlogie et al.   BLOOD

Engineered nanomedicine for myeloma and bone microenvironment targeting

(2014) A. Swami et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

ATP-triggered anticancer drug delivery

(2014) Ran Mo et al.   Nature Communications

Injectable Nano-Network for Glucose-Mediated Insulin Delivery

(2013) Zhen Gu et al.   ACS Nano

Poly(γ-benzyl-l-glutamate)-PEG-alendronate multivalent nanoparticles for bone targeting

(2013) Laura de Miguel et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

A biomimetic nanosponge that absorbs pore-forming toxins

(2013) Che-Ming J. Hu et al.   Nature Nanotechnology

Thrombosis is associated with inferior survival in multiple myeloma

(2012) S. Y. Kristinsson et al.   HAEMATOLOGICA

Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis

(2012) Joanna M Wardlaw et al.   LANCET

Latest advances and current challenges in the treatment of multiple myeloma

(2012) Anuj Mahindra et al.   Nature Reviews Clinical Oncology

Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma

(2012) Philip L. McCarthy et al.   NEW ENGLAND JOURNAL OF MEDICINE

Shear-Activated Nanotherapeutics for Drug Targeting to Obstructed Blood Vessels

(2012) N. Korin et al.   SCIENCE

Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform

(2011) C.-M. J. Hu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma

(2010) P. G. Richardson et al.   BLOOD

A shear gradient–dependent platelet aggregation mechanism drives thrombus formation

(2009) Warwick S Nesbitt et al.   NATURE MEDICINE

Acetalated dextran is a chemically and biologically tunable material for particulate immunotherapy

(2009) K. E. Broaders et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Bortezomib-induced peripheral neuropathy in multiple myeloma: a comprehensive review of the literature

(2008) A. A. Argyriou et al.   BLOOD

Acetal-Derivatized Dextran: An Acid-Responsive Biodegradable Material for Therapeutic Applications

(2008) Eric M. Bachelder et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma

(2008) R A Kyle et al.   LEUKEMIA

Mechanisms of Thrombus Formation

(2008) Bruce Furie et al.   NEW ENGLAND JOURNAL OF MEDICINE